Advertisement

Topics

Researchers Develop First-Ever Human Tissue Platform to Test Drugs for Colon Cancer

06:00 EDT 19 Jun 2017 | Weill Cornell Medical College

The first-ever “disease in a Petri dish” platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.

Original Article: Researchers Develop First-Ever Human Tissue Platform to Test Drugs for Colon Cancer

NEXT ARTICLE

More From BioPortfolio on "Researchers Develop First-Ever Human Tissue Platform to Test Drugs for Colon Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Colorectal Cancer
Colon or Colorectal cancer is the growth of malignant polyps on the colon, bowel, anus and rectum. Growths in these locations can be benign, and removed by colonoscopy, but they have a risk of becoming malignant.  About 10 per cent of bowel cancer...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...